Project Grant DP2CA290639

Award Date 9/1/23
Completion Date 8/31/26
Dollars Obligated $1.4M
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Cancer Institute
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
St. Louis, MO 63110, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $2,483,910 to The Washington University in St. Louis to conduct research on novel genetic mechanisms underlying primary immune regulation disorders. The 5-year project, which commenced on April 8, 2025, aims to investigate three key areas: 1) epigenetic mechanisms leading to autosomal random monoallelic expression in...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA 93.310 - Trans-NIH Research Support program provides $1,088,500.00 to The Washington University in St. Louis to conduct research on the neural circuits and cytokine codes that govern behavioral responses to inflammation. The project aims to elucidate how the immune and central nervous systems communicate to regulate motivation and mood, with a focus on chronic inflammatory conditions...
The Washington University Office of Sponsored Research Services Division has been awarded a $514,876 Project Grant by the National Science Foundation's (NSF) Biological Sciences program (CFDA 47.074). The grant will fund a 5-year research project to develop new computational methods for studying the evolution of intrinsically disordered protein regions (IDRs), which play essential biological roles despite not adopting a defined 3D structure. The project aims to identify signatures of...
The federal Project Grant award, valued at $250,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Washington University's Office of Sponsored Research Services Division. The award will fund a study on the "SUBCLINICAL PATHOPHYSIOLOGY OF MOTOR PROCESSING IN PEOPLE WITH MULTIPLE SCLEROSIS" over a 2-year period from September 30, 2024 to September 29, 2026. As a prominent private research university, The...
The U.S. National Institutes of Health (NIH) awarded a $1,671,116 Cooperative Agreement grant under the Trans-NIH Research Support (CFDA 93.310) program to The Washington University in St. Louis. The 3-year grant, running from September 2023 to August 2026, aims to develop a novel two-component optogenetic system for reversibly controlling the activity of user-defined synaptic connections between specific cell types in the brain. The project will involve engineering light-sensitive G...
The federal Project Grant award of $500,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research at Washington University to accelerate the diagnosis of inflammatory arthritis. The project aims to harness single-cell T cell-receptor sequencing to develop innovative diagnostic approaches. The research is being conducted at Washington University's Office of Sponsored Research Services Division over a 2-year performance period from...
This Project Grant award, totaling $1,983,531.00, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The purpose of the grant is to support the Medical Scientist Training Program (MSTP) at Washington University in St. Louis, which provides integrated pre-doctoral training in both clinical medicine and biomedical research to develop the next generation of physician-scientists. Key components of...
This $1,189,314 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training (CFDA 93.859) program supports research to elucidate the roles of protein disaggregases and develop enhanced disaggregases to counter diverse protein-misfolding disorders. The research program focuses on advancing the understanding of how disaggregases can counter protein misfolding, both in health and under stress, with the goal of applying...
This $1,201,221 Project Grant from the National Science Foundation's Division of Molecular and Cellular Biosciences, under the Biological Sciences program (CFDA 47.074), will fund research into the impact of charge regulation on conformational and phase equilibria of intrinsically disordered proteins. The awardee, Washington University in University City, Missouri, will leverage new computational and experimental methods to study how specific proteins known as intrinsically disordered proteins...
The Washington University Office of Sponsored Research Services Division was awarded a $460,659 Project Grant from the National Institute on Aging's Aging Research program (CFDA 93.866) to develop novel artificial intelligence (AI) models for integrating and interpreting multi-omics datasets related to exceptional longevity. The project aims to (1) develop unbiased and semi-guided graph neural network models to infer core signaling pathways associated with exceptional lifespan, and (2) create...

The Washington University Office of Sponsored Research Services Division in St. Louis, Missouri was awarded a $1,399,500 Project Grant by the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310). The grant, which began on September 1, 2023 and runs through August 31, 2026, will fund a research project aimed at uncovering the regulatory mechanisms underlying gene expression and how mutations in transcription factor regions can lead to pathological changes in gene expression. The project seeks to develop a high-resolution understanding of the role of intrinsically disordered regions in transcription factors and how they coordinate gene expression. The research will employ rational sequence design, in vitro analysis, and computational modeling to delineate the molecular basis for this process and its implications for diseases characterized by dysregulation of gene expression, such as cancer, neurodegeneration, and viral infections.

Generated 8/13/24, 6:55 AM